A Rare Combination of Dermatomyositis, Interstitial Pneumonia, and Lung Cancer in a Patient Treated with Immunosuppressive Therapy and Chemotherapy

被引：7

作者：

Daido, Wakako ^{[1
,2
]}

Yamasaki, Masahiro ^{[1
,2
]}

Morio, Yuka ^{[1
,2
]}

Funaishi, Kunihiko ^{[1
,2
]}

Ishiyama, Sayaka ^{[1
,2
]}

Deguchi, Naoko ^{[1
,2
]}

Taniwaki, Masaya ^{[1
,2
]}

Ohashi, Nobuyuki ^{[1
,3
]}

Hattori, Noboru ^{[4
]}

机构：

[1] Hiroshima Red Cross Hosp, Dept Resp Dis, Hiroshima, Japan

[2] Atom Bomb Survivors Hosp, Hiroshima, Japan

[3] Ohashi Clin, Tsukuba, Ibaraki, Japan

[4] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Mol & Internal Med, Hiroshima, Japan

来源：

INTERNAL MEDICINE | 2018年 / 57卷 / 06期

关键词：

dermatomyositis; interstitial pneumonia; lung cancer; WEEKLY PACLITAXEL; DISEASE; CYCLOSPORINE; CARBOPLATIN; POLYMYOSITIS; ASSOCIATION; EFFICACY; SAFETY;

D O I：

10.2169/internalmedicine.9642-17

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We herein report the rare case of co-occurring dermatomyositis (DM), interstitial pneumonia (IP), and lung cancer in a 59-year-old man. Computed tomography (CT) and positron emission tomography-CT showed the presence of a left lung tumor with IP, which was diagnosed as lung adenocarcinoma by a CT-guided tumor biopsy. We diagnosed DM based on the presence of myalgia, Gottron's papules, and anti-aminoacyl-tRNA synthetase antibody positivity in the patient. Co-occurrence of the above-mentioned three diseases is rare, and acute exacerbation of IP is a major cause of death in such cases. These patients can be treated with immunosuppressive therapy followed by chemotherapy.

引用

页码：849 / 853

页数：5

共 18 条

[1] Malignancy Is Associated with Dermatomyositis But Not Polymyositis in Northern New England, USA
Antiochos, Brendan B.
Brown, Lin A.
Li, Zhongze
Tosteson, Tor D.
Wortmann, Robert L.
Rigby, William F. C.
[J]. JOURNAL OF RHEUMATOLOGY, 2009, 36 (12) : 2704 - 2710
[2] Bardur S, 1992, NEW ENGL J MED, V326, P363
[3] Chen D, 2014, CLIN EXP RHEUMATOL, V32, P615
[4] Fujita Yu, 2011, Nihon Kokyuki Gakkai Zasshi, V49, P108
[5] HIDANO A, 1986, Journal of Dermatology (Tokyo), V13, P233
[6] Cyclosporine induces cancer progression by a cell-autonomous mechanism
Hojo, M
Morimoto, T
Maluccio, M
Asano, T
Morimoto, K
Lagman, M
Shimbo, T
Suthanthiran, M
[J]. NATURE, 1999, 397 (6719) : 530 - 534
[7] The Risk of Cytotoxic Chemotherapy-Related Exacerbation of Interstitial Lung Disease with Lung Cancer
Kenmotsu, Hirotsugu
Naito, Tateaki
Kimura, Madoka
Ono, Akira
Shukuya, Takehito
Nakamura, Yukiko
Tsuya, Asuka
Kaira, Kyoichi
Murakami, Haruyasu
Takahashi, Toshiaki
Endo, Masahiro
Yamamoto, Nobuyuki
[J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (07) : 1242 - 1246
[8] Mimori T, 2015, JPN J CHEST DIS, V74, P730
[9] The safety and efficacy of weekly paclitaxel in combination with carboplatin for advanced non-small cell lung cancer with idiopathic interstitial pneumonias
Minegishi, Yuji
Sudoh, Junko
Kuribayasi, Hideaki
Mizutani, Hideki
Seike, Masahiro
Azuma, Arata
Yoshimura, Akinobu
Kudoh, Shoji
Gemma, Akihiko
[J]. LUNG CANCER, 2011, 71 (01) : 70 - 74
[10] The Multicenter Study of a New Assay for Simultaneous Detection of Multiple Anti-Aminoacyl-tRNA Synthetases in Myositis and Interstitial Pneumonia
Nakashima, Ran
Imura, Yoshitaka
Hosono, Yuji
Seto, Minae
Murakami, Akihiro
Watanabe, Kizuku
Handa, Tomohiro
Mishima, Michiaki
Hirakata, Michito
Takeuchi, Tsutomu
Fujio, Keishi
Yamamoto, Kazuhiko
Kohsaka, Hitoshi
Takasaki, Yoshinari
Enomoto, Noriyuki
Suda, Takafumi
Chida, Kingo
Hisata, Shu
Nukiwa, Toshihiro
Mimori, Tsuneyo
[J]. PLOS ONE, 2014, 9 (01):

← 1 2 →